Viewing Expert Lorne Steinberg | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Viewing Expert

Lorne Steinberg , President & Portfolio Manager

Lorne Steinberg Wealth Management Inc

Address
1000 de la Gauchetiere Street West
Suite 3310
Montreal, QU
H3B 4W5

Contact Info
Telephone: 514-876-9888
Toll Free: 1-866-876-9888
Fax: 514-876-9994
Website: http://www.steinbergwealth.com

Bio:

Lorne Steinberg Wealth Management Inc. provides discretionary investment management services to individuals, corporations and non-profit organizations. At our firm, research is the lifeblood of our company. Through our disciplined investment approach, we aim to grow client capital over time within a lower risk framework -- capital preservation is of paramount importance. We are a management-owned firm and operate without external influence or pressure, free of ties to product providers and financial service institutions.


Date Signal Chart Symbol Company Opinion Price
2016-08-08 TOP PICK Must be logged in to use chart 6999-JP KOA Corporation

A 75-year-old Japanese company that is the best in the world in some very niche electronic component businesses, like specialized sensors. Like so many Japanese companies, it is trading for basically it’s working capital. You are basically getting the entire business for free. It has no debt. Dividend yield of 3.49%.


Price:
$0.000
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Yes
2016-08-08 N/A Must be logged in to use chart A Commentary A Comment -- General Comments From an Expert

Markets. The “Lower for longer” interest rate scenario has a huge impact in his investment process. We need to always remember that the value of stocks are not pieces of paper, they are businesses. The value of a business will always be the function of its long-term earnings, cash flow and earnings growth. Just because interest rates are low, as a long-term investor, you shouldn’t be buying things just because they are cheaper than the market, if the market is too expensive. There are a number of sectors that have gotten out of whack. With this near zero world we are living in, people are starting to buy stocks as if they are bonds, and as if dividends will never get cut. No one ever predicted that interest rates would be here. We have never seen negative interest rates before. If these rates continue for 5, 6, 7 years, then owning these stocks makes a lot of sense. However, that is impossible to predict. Obviously when equity prices rise, the risk level rises, and you are better off selling that which is expensive, buying that which has value, and in his view, holding some cash as well. If you are an owner of government bonds, that game is over and dead, and is a recipe to losing money against inflation, even at low levels of inflation. If you hold bond funds or regular bonds, you should sell them. Also, the consumer sector has become very, very expensive. He is still finding value in Japan, which remains the cheapest market in the world, and is the 3rd largest market globally. He is finding value in US large technology companies, as well as the financial sector, which has been beaten down.


Price:
$0.020
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
_N/A
2016-08-08 HOLD Must be logged in to use chart A Commentary A Comment -- General Comments From an Expert

Canadian banks. They’ve done a phenomenal job. Canadian rules make it tougher for them to lever themselves up as much as other global banks. They are all very tied to the Canadian retail sector. If the housing market ever softens, in Toronto or Vancouver, there is room for earnings to soften a little, and probably giving a better entry point.


Price:
$0.020
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
No
2016-08-08 COMMENT Must be logged in to use chart ADW.A-T Andrew Peller

Doesn’t own dual class share companies, but this one has been an amazing growth story. Incredibly successful. If he didn’t have an issue with dual class shares, he might actually buy this. It is unbelievable to him that in an industry which is low growth, they have made some great acquisitions and they cover all the basic markets from lower end to higher end. Have done a fantastic job. Truly a Canadian success story.


Price:
$28.040
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
No
2016-08-08 COMMENT Must be logged in to use chart ARX-T Arc Resources Ltd

This is, in a large part, dependent on the commodity price. It used to be an income trust, and has always been a pretty well run company. He doesn’t own the Canadian energy sector, and is not a huge fan of the natural gas side. There is so much gas around, that it is hard to see gas prices rising much from here. No one is making much money at these prices. Costs and environmental costs keep going up.


Price:
$23.660
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
No
2016-08-08 COMMENT Must be logged in to use chart BAC-N Bank of America

Chairman and CEO is the same. He is a fan of these being separated. Feels that once these positions have been given, if you separate them it would feel like it was a demotion. The real question is, how strong is the board. He is a fan of stronger boards.


Price:
$15.130
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
_N/A
2016-08-08 DON'T BUY Must be logged in to use chart BMW-GR Bayerische Motoren Werke AG

Glaxo Smith (GSK-N) or BMW (BMW-GR)? Two entirely different companies. A global drug company and an automobile company. This is clearly going to be more of a cyclical business, tied to the economy. To him, there are better places to look for value.


Price:
$0.000
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
No
2016-08-08 COMMENT Must be logged in to use chart BMY-N Bristol Myers Squibb

Had a huge disappointment on one of their drug trials. The business is all about the pipeline. Every major drug company is having trouble coming up with great new drug ideas. What they are doing is cutting back on R&D spending. Thinks this still has some downside. Would be looking at this after another 15% drop in the share price. The dividend is secure.


Price:
$60.300
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Unknown
2016-08-08 PAST TOP PICK Must be logged in to use chart CSCO-Q Cisco

(A Top Pick Oct 5/15. Up 18.57%.) He still loves this. Has $40 billion of net cash, and is throwing off $10 billion a year of free cash flow. They are buying back shares all the time and will probably be raising dividend by 10% a year for years to come. They are #1 in the world in their 4 major businesses, all of which are growth businesses. Still generating revenue growth, even with a strong US$, which is not an easy thing to do. Revenues per share is still rising. EPS is in the 7%-10% range for the next several years out. Have phenomenal franchises and are a free cash flow generator. Selling at a pretty cheap multiple, especially after Xing out the cash.


Price:
$31.010
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Yes
2016-08-08 COMMENT Must be logged in to use chart DOW-N Dow Chemical

This has a planned merger with DuPont (DD-N), probably later this year or early next. These are both trading as if they are already a merged entity. He is of mixed feelings. There will be a bunch of cost cutting, which should boost earnings in the short term. Integrating these behemoth companies is never an easy task.


Price:
$53.600
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Unknown
2016-08-08 COMMENT Must be logged in to use chart F-N Ford Motor

Too risky? Came out of the financial crisis and have restructured into far better shape. The trouble with cyclical companies is that they end up paying out too much in dividends, and then, if the cycle turns nasty, they have to cut them. He doesn’t see anything imminent in terms of dividend cuts. It is probably okay, but keep in mind this is a cyclical company.


Price:
$12.180
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Unknown
2016-08-08 PAST TOP PICK Must be logged in to use chart GLW-N Corning Inc

(A Top Pick Oct 5/15. Up 31.92%.) This was famous for fibre optics, and now they are famous for making Gorilla Glass for the iPhone, TVs, etc. This came back after the whole .com thing. They always stuck with their businesses. Just sold their holding in Dow Corning for almost $5 billion, and are sitting with a ton of cash. Buying back massive amounts of stock. Earnings are growing at double digits. Huge free cash flow and is extremely cheap. Thinks the stock is worth about $30 a share.


Price:
$22.800
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Yes
2016-08-08 COMMENT Must be logged in to use chart GM-N General Motors Corporation

Too risky? Came out of the financial crisis and have restructured into far better shape. The trouble with cyclical companies is that they end up paying out too much in dividends, and then, if the cycle turns nasty, they have to cut them. He doesn’t see anything imminent in terms of dividend cuts. It is probably okay, but keep in mind this is a cyclical company.


Price:
$30.880
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Unknown
2016-08-08 TOP PICK Must be logged in to use chart GS-N Goldman Sachs

This has suffered along with all the global investment banks. They don’t have any serious regulatory issues, but are all suffering from low interest rates as well as regulatory oversight issues, having to pull capital out of trading businesses. The great news is that while everybody else is reducing exposure to trading businesses, this bank is not. There is going to be, and already is, a lot less competition in those trading businesses that they run so well and so shrewdly. Trading at about 10X earnings, a slight discount to tangible BV. Dividend yield of 1.6%.


Price:
$162.830
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
Yes
2016-08-08 DON'T BUY Must be logged in to use chart GSK-N GlaxoSmithKline PLC

Glaxo Smith (GSK-N) or BMW (BMW-GR)? Two entirely different companies. A global drug company and an automobile company. This is going to be more of a somewhat stable profit and dividend payer. The drug companies all have phenomenal cash flows. To him, there are better places to look for value.


Price:
$44.410
Subject:
VALUE STOCKS & HIGH YIELD BONDS
Bias:
BEARISH on BONDS
Owned:
No
Showing 1 to 15 of 513 entries
<< < 1 2 3 4 5 > >>

1 Comment

izzyKap

April 25th 2014 at 11:25am

I viewed Lorne for the first time on BNN April 2014. My impression is that he is a thoughtful incisive professional with impressive brain power! I intend to keep track of his recommendations.


You must be logged in to comment.